| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Frequency Therapeutics Inc (NASDAQ: FREQ)
FREQ Technical Analysis
5
| As on 9th Jun 2023 FREQ STOCK Price closed @ 0.38 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.44 & Strong Sell for SHORT-TERM with Stoploss of 4.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FREQSTOCK Price
| Open | 0.39 | Change | Price | % |
| High | 0.40 | 1 Day | -0.01 | -2.56 |
| Low | 0.37 | 1 Week | 0.03 | 8.57 |
| Close | 0.38 | 1 Month | -0.01 | -2.56 |
| Volume | 43800 | 1 Year | -5.07 | -93.03 |
| 52 Week High 5.72 | 52 Week Low 0.35 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FREQ Daily Charts |
FREQ Intraday Charts |
Whats New @ Bazaartrend |
FREQ Free Analysis |
|
|
FREQ Important Levels Intraday
| RESISTANCE | 0.44 |
| RESISTANCE | 0.42 |
| RESISTANCE | 0.41 |
| RESISTANCE | 0.40 |
| SUPPORT | 0.36 |
| SUPPORT | 0.35 |
| SUPPORT | 0.34 |
| SUPPORT | 0.32 |
FREQ Forecast May 2024
| 4th UP Forecast | 3.83 |
| 3rd UP Forecast | 2.72 |
| 2nd UP Forecast | 2.04 |
| 1st UP Forecast | 1.36 |
| 1st DOWN Forecast | -0.6 |
| 2nd DOWN Forecast | -1.28 |
| 3rd DOWN Forecast | -1.96 |
| 4th DOWN Forecast | -3.07 |
FREQ Weekly Forecast
| 4th UP Forecast | 1.83 |
| 3rd UP Forecast | 1.36 |
| 2nd UP Forecast | 1.08 |
| 1st UP Forecast | 0.79 |
| 1st DOWN Forecast | -0.03 |
| 2nd DOWN Forecast | -0.32 |
| 3rd DOWN Forecast | -0.60 |
| 4th DOWN Forecast | -1.07 |
FREQ Forecast2024
| 4th UP Forecast | 10.86 |
| 3rd UP Forecast | 7.5 |
| 2nd UP Forecast | 5.42 |
| 1st UP Forecast | 3.34 |
| 1st DOWN Forecast | -2.58 |
| 2nd DOWN Forecast | -4.66 |
| 3rd DOWN Forecast | -6.74 |
| 4th DOWN Forecast | -10.1 |
Frequency Therapeutics Inc ( NASDAQ USA Symbol : FREQ )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FREQ Business Profile
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, Mass General Brigham, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Address: 75 Hayden Avenue, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service